Wellington Management Group LLP Apellis Pharmaceuticals, Inc. Transaction History
Wellington Management Group LLP
- $503 Billion
- Q1 2025
A detailed history of Wellington Management Group LLP transactions in Apellis Pharmaceuticals, Inc. stock. As of the latest transaction made, Wellington Management Group LLP holds 12,303,252 shares of APLS stock, worth $300 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
12,303,252Holding current value
$300 Million% of portfolio
0.05%Shares
22 transactions
Others Institutions Holding APLS
# of Institutions
285Shares Held
124MCall Options Held
921KPut Options Held
761K-
Avoro Capital Advisors LLC New York, NY12.2MShares$298 Million4.32% of portfolio
-
Eco R1 Capital, LLC San Francisco, CA11.9MShares$290 Million20.45% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.1MShares$247 Million0.0% of portfolio
-
Morgan Stanley New York, NY9.63MShares$235 Million0.02% of portfolio
-
Black Rock Inc. New York, NY5.8MShares$141 Million0.01% of portfolio
About Apellis Pharmaceuticals, Inc.
- Ticker APLS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 109,865,000
- Market Cap $2.68B
- Description
- Apellis Pharmaceuticals, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of therapeutic compounds through the inhibition of the complement system for autoimmune and inflammatory diseases. The company's lead product candidate is pegcetacoplan that is in Phase III clinical trials for...